Neuroproteomics: An insight into ALS

Neurological Research

Volumn 34, Issue 10, 2012, Pages 937-943

  Mendonca D M F ^a   Pizzati, L ^b   Mostacada, K ^b   Martins, S C de S ^b   Higashi, R ^c   Ayres Sa L ^b   Moura Neto, V ^b   Chimelli, L ^b   Martinez, A M B ^b  

^a FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c Inst de Neurologia Deolindo Couto   (Brazil)

Author keywords

Amyotrophic lateral sclerosis; Cerebrospinal fluid; MALDI TOF; Proteomics

Indexed keywords

IRON; PARKIN; PROTEASOME; ZINC;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CEREBROSPINAL FLUID; CHEMICAL BINDING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NEUROPROTEOMICS; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL ELECTROPHORESIS;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84869170599     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132812Y.0000000092     Document Type: Article

References (34)

1. Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 2009; 4:3.
2. Mendonça DM, Chimelli L, Martinez AM. Expression of ubiquitin and proteasome in motorneurons and astrocytes of spinal cords from patients with amyotrophic lateral sclerosis. Neurosci Lett. 2006;404(3):315-9.
3. Rothstein JD. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol. 2009;65(Suppl 1):3-9.
4. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293-9.
5. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-54.
6. Shevchenko A, Wilm M, Vorm O, Mann M. Mass Spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal Chem. 1996;68:850-8.
7. Freed EF, Bleichert F, Dutca LM, Baserga SJ. When ribosomes go bad: diseases of ribosome biogenesis. Mol Biosyst. 2010;6(3):481-93.
8. Pei JJ, Björkdahl C, Zhang H, Zhou X, Winblad B. p70 S6 kinase and tau in Alzheimer's disease. J Alzheimers Dis. 2008;14(4):385-92.
9. Giordano G, Sánchez-Pérez AM, Montoliu C, Berezney R, Malyavantham K, Costa LG, et al. Activation of NMDA receptors induces protein kinase A-mediated phosphorylation and degradation of matrin 3. Blocking these effects prevents NMDA-induced neuronal death. J Neurochem. 2005;94(3): 808-18.
10. Zeitz MJ, Malyavantham KS, Seifert B, Berezney R. Matrin 3: chromosomal distribution and protein interactions. J Cell Biochem. 2009;108(1):125-33.
11. Senderek J, Garvey SM, Krieger M, Guergueltcheva V, Urtizberea A, Roos A, et al. Autosomal-dominant distal myopathy associated with a recurrent missense mutation in the gene encoding the nuclear matrix protein, matrin 3. Am J Hum Genet. 2009;84(4):511-8.
12. Przygodzka P, Boncela J, Cierniewski CS. Matrin 3 as a key regulator of endothelial cell survival. Exp Cell Res. 2011;317(6):802-11.
13. Oveland E, Gjertsen BT, Wergeland L, Selheim F, Fladmark KE, Hovland R. Ligand-induced Flt3-downregulation modulates cell death associated proteins and enhances chemosensitivity to idarubicin in THP-1 acute myeloid leukemia cells. Leuk Res. 2009;33(2):276-87.
14. Giordano G, Sánchez-Pérez AM, Montoliu C, Berezney R, Malyavantham K, Costa LG, et al. Activation of NMDA receptors induces protein kinase A-mediated phosphorylation and degradation of matrin 3. Blocking these effects prevents NMDA-induced neuronal death. J Neurochem. 2005;94(3): 808-18.
15. 2z/calmodulinbinding protein cleaved by caspases. Biochem Biophys Res Commun. 2007;361(2):281-6.
16. 2z transport. J Biol Chem. 2010;285(7):4621-8.
17. Nakamizo T, Urushitani M, Inoue R, Shinohara A, Sawada H, Honda K, et al. Protection of cultured spinal motor neurons by estradiol. Neuroreport. 2000;11(16):3493-7.
18. Hrycay EG, Bandiera SM. Expression, function and regulation of mouse cytochrome P450 enzymes: comparison with human P450 enzymes. Curr Drug Metab. 2009;10(10):1151-83.
19. Murphy MG, Spence MW. Acid:coenzyme A ligase in brain: fatty acid specificity in cellular and subcellular fractions. J Neurochem. 1982;38(3):675-9.
20. Sasaki S, Shionoya A, Ishida M, Gambello MJ, Yingling J, Wynshaw-Boris A, et al. A LIS1/NUDEL/cytoplasmic dynein heavy chain complex in the developing and adult nervous system. Neuron. 2000;28:681-96.
21. Suzuki T, Ueda A, Kobayashi N, Yang J, Tomaru K, Yamamoto M, Takeno M, Ishigatsubo Y. Proteasome-dependent degradation of alpha-catenin is regulated by interaction with ARMc8alpha. Biochem J. 2008;411(3):581-91.
22. Kimata Y, Baxter JE, Fry AM, Yamano H. A role for the Fizzy/Cdc20 family of proteins in activation of the APC/C distinct from substrate recruitment. Mol Cell. 2008;32 (4):576-83.
23. Goulet I, Boisvenue S, Mokas S, Mazroui R, Cote J. TDRD3, a novel Tudor domain-containing protein, localizes to cytoplasmic stress granules. Hum Mol Genet. 2008;17:3055-74.
24. White HE, Hall VJ, Cross NC. Methylation-sensitive highresolution melting-curve analysis of the SNRPN gene as a diagnostic screen for Prader-Willi and Angelman syndromes. Clin Chem. 2007;53(11):1960-2.
25. Hadari YR, Arbel-Goren R, Levy Y, Amsterdam A, Alon R, Zakut R, et al. Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis. J Cell Sci. 2000;113(Pt 13):2385-97.
26. Gil OD, Zanazzi G, Struyk AF, Salzer JL. Neurotrimin mediates bifunctional effects on neurite outgrowth via homophilic and heterophilic interactions. J Neurosci. 1998;18(22): 9312-25.
27. McCawley LJ, Matrisian LM. Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol.2001;13(5):534-40.
28. Glatt H, Boeing H, Engelke CE, Ma L, Kuhlow A, Pabel U, et al. Human cytosolic sulphotransferases: Genetics, characteristics, toxicological aspects. Mutat Res. 2001;482:27-40.
29. Lee DH, Jin SG, Cai S, Chen Y, Pfeifer GP, O'Connor TR. Repair of methylation damage in DNA and RNA by mammalian AlkB homologues. J Biol Chem. 2005;280:39448-59.
30. Ryberg H, An J, Darko S, Lustgarten JL, Jaffa M, Gopalakrishnan V, et al. Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics. Muscle Nerve. 2010;42(1):104-11.
31. Pasinetti GM, Ungar LH, Lange DJ, Yemul S, Deng H, Yuan X, et al. Identification of potential CSF biomarkers in ALS. Neurology. 2006;66(8):1218-22.
32. Wilson ME, Boumaza I, Lacomis D, Bowser R. Cystatin C: a candidate biomarker for amyotrophic lateral sclerosis. PloS OONE. 2010;5(12):e15133.
33. Zhou JY, Afjehi-Sadat L, Asress S, Duong DM, Cudkowicz M, Glass JD, et al. Glass, and Junmin Peng. Galectin-3 is a candidate biomarker for ALS: discovery by a proteomics approach. J Proteome Res. 2010;9(10):5133-41.
34. Mendonça DM, Martins SC, Higashi R, Muscara MN, Neto VM, Chimelli L, et al. Neurofilament heavy subunit in cerebrospinal fluid: a biomarker of amyotrophic lateral sclerosis? Amyotroph Lateral Scler. 2011;12(2):144-7.